Search
Quoin Pharmaceuticals Ltd
QNRXAdd to Watchlist
5.235USD
+0.145+2.85%
Close 08-14 16:00（ET）Quotes delayed by 15 min
359.34MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Quoin Pharmaceuticals Ltd is 8.00, ranking 170 out of 387 in the Biotechnology & Medical Research industry. The average price target is 30.00, with a high of 70.00 and a low of 25.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
21.400
Target Price
+320.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Quoin Pharmaceuticals Ltd
QNRX
4
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Quoin Pharmaceuticals Ltd's price target?
Analysts forecast that Quoin Pharmaceuticals Ltd's price target is USD 30.00, with the highest forecast at USD 70.00 and the lowest forecast at USD 25.00.
How have Quoin Pharmaceuticals LtdQNRX's recent earnings per share performed?
The market expectation was USD -61.79, while Quoin Pharmaceuticals LtdQNRX's earnings per share (EPS) for the previous quarter was USD -60.64. EPS for the next quarter is expected at USD -1.61.
What is the analyst rating for Quoin Pharmaceuticals Ltd?
Based on the ratings of Quoin Pharmaceuticals Ltd's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.